Catalyst Biosciences has named Nassim Usman, Ph.D., as its new CEO.
Progen Industries hired Justus Homburg as its new CEO.
Keryx Biopharmaceuticals named Ronald C. Renaud, Jr. as senior vice president, CFO and treasurer.
Conforma Therapeutics has named John E. Crawford to the newly created position of CFO.
Vitae Pharmaceuticals appointed Tina Fiumenero as senior vice president, finance and administration.
Joseph Spagnardi has been promoted to senior vice president, general counsel and secretary of Inspire Pharmaceuticals.
Akorn has named David White, Ph.D. as vice president, new product development.
IsoTis OrthoBiologics has appointed Alan Donze as vice president sales.
Spectranetics has hired Stephen D. Okland, Jr., 42, as vice president of sales.
Dr Daniel Teper has joined Bionest Partners as managing director, North America.
ARYx Therapeutics named Herm Rosenman to its board of directors.
Synthetech announced that its board of directors has established a strategic development committee and appointed Dr. Daniel Fagan, chairman of the board, as the sole committee member.
Ceragenix Pharmaceuticals has appointed Donald Leung, M.D., Ph.D., to its scientific advisory board.
GlycoFi announced that Gerald Fink, Ph.D. of the Whitehead Institute and MIT has joined GlycoFi's scientific advisory board.
VisualSonics has named Jonathan Lindner, MD, as chief molecular advisor.
Neuro-Hitech Pharmaceuticals has appointed Mark Auerbach chairman of its board of directors.
Isotechnika elected Franklin M. Berger, CFA, to its board of directors.
TaiGen Biotechnology elected William Keller to its board.